Literature DB >> 11971864

High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1-->3GalNAc pyranoside.

Hiroko Ideo1, Akira Seko, Takashi Ohkura, Khushi L Matta, Katsuko Yamashita.   

Abstract

Galectin-4 is a member of galectin family and has two carbohydrate recognition domains. Although galectin-4 has been thought to function in cell adhesion, its precise carbohydrate binding specificity has not yet been clarified. We studied the carbohydrate binding specificity of galectin-4 comparatively with that of galectin-3, using surface plasmon resonance, galectin-3- or -4-Sepharose column chromatography and the inhibition assay of their binding to immobilized asialofetuin. Galectin-3 broadly recognized lactose, type 1, type 2, and core 1. The substitution at the C-2 and C-3 position of beta-galactose in these oligosaccharides with alpha-fucose, alpha-GalNAc, alpha-Neu5Ac, or sulfate increased the binding ability for galectin-3, whereas the substitution at the C-4 or C-6 position diminished the affinity. In contrast, galectin-4 had quite weak affinity to lactose, type 1, and type 2 (K(d) congruent with 8 x 10(-4) M). Galectin-4 showed weak binding ability to core 1 and C-2' or -3'-substituted lactose, type 1, and type 2 with alpha-fucose, alpha-GalNAc, or sulfate (K(d) : 5 x 10(-5) approximately 3 x 10(-4) M). Interestingly, the K(d) value, 3.4 x 10(-6) M, of SO(3)(-)-->3Galbeta1-->3GalNAc-O-Bn to galectin-4 at 25 degrees C was two orders of magnitude lower than that of core 1-O-Bn. 3'-Sialylated core 1 had very weak affinity to galectin-4, suggesting that 3'-O-sulfation of core 1 is critical for the recognition. These results suggest that galectin-4 has a unique carbohydrate binding specificity and interacts with O-linked sulfoglycans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971864     DOI: 10.1093/glycob/12.3.199

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  31 in total

1.  Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells.

Authors:  Sean R Stowell; Sougata Karmakar; Caleb J Stowell; Marcelo Dias-Baruffi; Rodger P McEver; Richard D Cummings
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

2.  Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans.

Authors:  Hiroko Ideo; Tsutomu Matsuzaka; Takamasa Nonaka; Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

Review 3.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

Review 4.  Roles of galectins in inflammatory bowel disease.

Authors:  Akira Hokama; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

5.  Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.

Authors:  René Roy; Yihong Cao; Herbert Kaltner; Naresh Kottari; Tze Chieh Shiao; Karima Belkhadem; Sabine André; Joachim C Manning; Paul V Murphy; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2016-12-24       Impact factor: 4.304

Review 6.  Key regulators of galectin-glycan interactions.

Authors:  Nourine A Kamili; Connie M Arthur; Christian Gerner-Smidt; Eden Tafesse; Anna Blenda; Marcelo Dias-Baruffi; Sean R Stowell
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

7.  Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle.

Authors:  Marcelo Dias-Baruffi; Sean R Stowell; Shuh-Chyung Song; Connie M Arthur; Moonjae Cho; Lilian C Rodrigues; Marlise A B Montes; Marcos A Rossi; Judith A James; Rodger P McEver; Richard D Cummings
Journal:  Glycobiology       Date:  2010-01-05       Impact factor: 4.313

Review 8.  Galectin-4 in normal tissues and cancer.

Authors:  Margaret E Huflejt; Hakon Leffler
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

9.  Potential tumor markers for human gastric cancer: an elevation of glycan:sulfotransferases and a concomitant loss of alpha1,2-fucosyltransferase activities.

Authors:  E V Chandrasekaran; Jun Xue; Conrad Piskorz; Robert D Locke; Károly Tóth; Harry K Slocum; Khushi L Matta
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-11       Impact factor: 4.553

Review 10.  Is the sugar always sweet in intestinal inflammation?

Authors:  Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.